Greek Organisation of Football Prognostics SA Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Buy

52

GOFPY
Greek Organisation of Football Prognostics SA

Last Price:

$10.70

Seasonality Move:

4.04%

Sell

18

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:

$33.50

Seasonality Move:

-0.96%

Buy

52

Greek Organisation of Football Prognostics SA (GOFPY) is a Buy

Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?

The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $10.62. The Score for GOFPY is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
GOFPY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

18

Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $32.84. The Score for RARE is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
RARE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

GOFPY Stock Price Chart

What is Greek Organisation of Football Prognostics SA's stock price today?

The Greek Organisation of Football Prognostics SA share price today is $10.62

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GOFPY is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

The Ultragenyx Pharmaceutical, Inc. share price today is $32.84

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

GOFPY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.1	Buy
Relative Strength Index (14 RSI):	53.41	Buy
Chaikin Money Flow:	-23212	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	( - )	Buy
Bollinger Bands (100):	( - )	Buy

RARE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	4.67	Buy
Relative Strength Index (14 RSI):	41.45	Sell
Chaikin Money Flow:	-1089594	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(32.6 - 35.94)	Sell
Bollinger Bands (100):	(29.09 - 34.15)	Buy

GOFPY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	10.74	Sell
20-day SMA:	10.47	Buy
50-day SMA:	10.46	Buy
200-day SMA:	10.89	Sell
8-day EMA:	10.66	Sell
20-day EMA:	10.55	Buy
50-day EMA:	10.6	Buy
200-day EMA:	10.57	Buy

RARE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	35.17	Sell
20-day SMA:	34.68	Sell
50-day SMA:	33.7	Sell
200-day SMA:	33.61	Sell
8-day EMA:	13.04	Buy
20-day EMA:	5.99	Buy
50-day EMA:	2.54	Buy
200-day EMA:	0.65	Buy

Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Greek Organisation of Football Prognostics SA Technical Analysis

	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18	Dec 19
	Dec
	08	09	10	11	12	15	16	17	18	19
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16	Dec 17	Dec 18
	Dec
	05	08	09	10	11	12	15	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):